PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedgeneJournal of Medical GeneticsCurrent TOCInstructions for authors
 
J Med Genet. Nov 1998; 35(11): 951–953.
PMCID: PMC1051491
A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.
E S Moreira, M Vainzof, S K Marie, V Nigro, M Zatz, and M R Passos-Bueno
Departamento de Biologia, Instituto de Biociências, Universidade de São Paulo, SP, Brazil.
Abstract
Among the heterogeneous group of autosomal recessive limb-girdle muscular dystrophies (AR LGMDs), the sarcoglycanopathies (LGMD2C-2F) represent a subgroup characterised by defects in the gamma, alpha, beta, and delta sarcoglycan genes, respectively. Genotype-phenotype correlations in these forms of AR LGMD are important to enhance our understanding of protein function. Regarding LGMD2F, only two homozygous frameshift mutations have been reported to date in patients with a severe phenotype. In the present report, through screening 23 unrelated AR LGMD patients, we identified three subjects with LGMD2F, two with a previously reported frameshift mutation and the other homozygous for a new missense mutation in the delta sarcoglycan gene. Interestingly, this new mutation is also associated with a severe clinical course. In addition, our results suggest that this form of severe AR LGMD is not very rare in our population.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (629K), or click on a page image below to browse page by page.
Images in this article
Click on the image to see a larger version.
Articles from Journal of Medical Genetics are provided here courtesy of
BMJ Group